
Dapasmart 5mg Tablet
Marketer
Healing Pharma India Pvt Ltd
Salt Composition
Dapagliflozin (5mg)
Overview Dapasmart 5mg Tablet
GlucoSmart 5mg tablets are indicated for managing type 2 diabetes, either independently or as part of a combined medication regimen. They effectively regulate elevated blood glucose, mitigating the risk of severe diabetic complications and contributing to heart health prevention. GlucoSmart 5mg can be administered with or without food, consistently at the same time daily, as prescribed by your physician. Discontinuing treatment without medical consultation can lead to elevated blood sugar and potentially serious consequences such as renal impairment and vision loss. This medication forms part of a comprehensive diabetes management plan incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Commonly reported adverse effects include vaginal yeast infections, upper respiratory tract inflammation, and urinary tract infections; dehydration is also possible. Adequate hydration is crucial, and maintaining proper hygiene helps prevent genital infections. Prior to commencement, disclose any kidney or liver issues, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical advice. Limit alcohol consumption, as it may heighten the risk of certain side effects. Regular blood glucose monitoring is essential during treatment.
Primary Ingredients of Dapasmart 5mg Tablet
There is no text provided to rephrase.
Uses of Dapasmart 5mg Tablet
Managing type 2 diabetes
Major Benefits of Dapasmart 5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 5mg Dapasmart tablet whole; avoid crushing, chewing, or breaking it. While consumption with or without food is acceptable, consistent timing is recommended for optimal results.
Common Side effects of Dapasmart 5mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapasmart 5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the 5mg Dapasmart tablet whole; do not crush, chew, or break it. While this medication can be taken with or without food, consistency is key—take it at the same time each day.
How Dapasmart 5mg Tablet works:
Glucodown 5mg tablets are used to manage diabetes. They function by facilitating the excretion of surplus glucose via the kidneys.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Dapasmart 5mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Dapasmart 5mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Dapasmart 5mg Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
The use of Dapasmart 5mg tablets is inadvisable for individuals with kidney impairment and should be avoided. Seek medical advice before use.
LiverSAFE IF PRESCRIBED
Dapasmart 5mg tablets can be administered to patients with hepatic impairment without the need for dosage modification.
What if you forget to take Dapasmart 5mg Tablet :
Should you forget a Dapasmart 5mg Tablet dose, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Dapasmart 5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
